Chemicals company Chemours announced it placed its chief executive officer, chief financial officer, and principal accounting officer on leave pending completion of an internal review into potential material weaknesses in its internal control over financial reporting (ICFR).
The company announced the designations Wednesday, along with the appointments of Denise Dignam as interim CEO and Matt Abbott as interim CFO and principal financial and accounting officer. Chemours also disclosed a delay in the filing of its 2023 annual report as it is conducting its investigation.
